Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Massive study aims to unlock secrets of childhood nerve and muscle diseases

NCT ID NCT01568658

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Sep 10, 2026 · Updated 5 times

Summary

This long-term study looks at children and adults with inherited nerve and muscle disorders that start early in life, like muscular dystrophy. Researchers will track symptoms over time and collect genetic samples from affected individuals, their family members, and healthy volunteers. The goal is to better understand these conditions and develop tools for future clinical trials.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this study could identify better ways to measure disease progression and find genetic causes, helping design future treatments.
What could go wrong
This is an observational study, not testing a treatment. It may not directly lead to new therapies, and results depend on long-term participation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

2,586 people

The number who actually took part.

Started

Mar 2012

Lead sponsor

A government research agency

The lead sponsor is the US National Institutes of Health.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Affected probands with the following categories of childhood onset inherited neurological disorders will be enrolled:-peripheral neuropathies; -muscular dystrophies and myopathies; -congenital muscular dystrophies and congenital myopathies; -disorders of the neuromuscular junction; -motor neuron disorders; -neuromotor or movement disorders; -disorders of brain development; -neurometabolic disorders; -disorders that have a phenotype suggestive of neurogenetic or neuromuscular disease but which have not yet been genetically confirmed. Families of affected probands, with known or suspected inherited neurological disorders of childhood onset will be enrolled. Healthy volunteers will enrolled for one-time imaging procedures. A single patient with compound heterozygous FDX2 mutations will be enrolled under an emergency IND for use of Idebenone for slowing progression of subacute blindness.

Ages

1 day to 100 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

* INCLUSION AND EXCLUSION CRITERIA: Probands inclusion criteria Phase 1: 1. Aged 4 weeks and older 2. Documentation of a personal history of a childhood-onset, hereditary/familial, neurological disorder or later onset of a disease that more commonly has childhood onset. Acceptable documentation includes evaluation through any or all of the following evaluations done prior to enrollment. 1. Medical history, including family history information 2. Physical examination 3. Muscle, nerve, or skin biopsy 4. Magnetic resonance imaging (MRI) 5. Electromyography (EMG) 6. Nerve conduction study (NCS) 7. Electroencephalogram (EEG) 8. Muscle ultrasound 9. Genetic, metabolic, or other laboratory testing such as increased serum Creatine Kinase (CK) and abnormal serum lactate/pyruvate ratio. Exclusion criteria for probands Phase 1: 1. Individuals who are unable or unwilling to be examined 2. Minors who do not hve a parent or guardian able to provide informed consent 3. Adults seen offsite who are unable to provide their own consent Probands inclusion criteria Phase 2: 1. Aged 4 weeks and older 2. Documentation of a defined childhood onset neuromuscular and neurogenetic disorders through phase 1 testing. Exclusion criteria for probands Phase 2: 1. Individuals who are unable or unwilling to be examined. 2. Adults who are unable to provide their own consent and who have not previously appointed an individual with Durable Power of Attorney (DPA) or who are unable to appoint a DPA or guardian. 3. Minors who do not have a parent or guardian able to provide informed consent. 4. Adults seen offsite who are unable to provide their own consent. Unaffected Family members - Inclusion Criteria: 1. Unaffected family members must be related by blood to a proband enrolled in the study. Biological relations may include first (parent or sibling), second (grandparents, aunts, uncles, half siblings) and third degree relatives (cousins). 2. Age 4 weeks and older. Unaffected Family members - Exclusion Criteria: 1. Individuals whom are unable or unwilling to be examined. 2. Family members who are showing symptoms of the familial neurogenetic or neuromuscular condition (these may be enrolled as probands). 3. Neonates. 4. Adults who are unable to provide their own consent. Healthy Volunteers - Inclusion Criteria: 1. Must be unaffected by a neurological condition. 2. Willing and able to comply with all protocol requirements and procedures, including MRI without sedation and without contrast. 3. Able to give informed assent and parent(s)/legal guardian to give informed consent in writing signed by the subject and/or parent(s)/legal guardian. Healthy Volunteers - Exclusion Criteria: 1. Healthy volunteers who have metal objects in their body that are not MRI-safe. These include the following objects: 1) pacemakers or other implanted electrical devices; 2) brain stimulators; 3) some types of dental implants; 4) aneurysm clips (metal clips on the wall of a large artery); 5) metallic prostheses (including metal pins and rods, heart valves, and cochlear implants; 6) implanted delivery pump; 7) permanent eye liner; or 8) shrapnel fragments. 2. Healthy volunteers who have a fear of closed spaces. 3. Neonates. 4. Pregnant

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hereditary spastic paraplegias are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • National Institutes of Health Clinical Center

    Bethesda, Maryland, 20892, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.